Lack of expression of transforming growth factor-β type II receptor associated with malignant progression in human salivary gland cell clones
- 11 June 1996
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 66 (6) , 802-805
- https://doi.org/10.1002/(sici)1097-0215(19960611)66:6<802::aid-ijc16>3.0.co;2-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.Molecular and Cellular Biology, 1994
- Close Correlation between the Dephosphorylation of p53 and Growth Suppression by Transforming Growth Factor-β1 in Nasopharyngeal Carcinoma Cells Transduced with Adenovirus Early Region GenesJapanese Journal of Cancer Research, 1994
- Cloning of a TGF$beta; type I receptor that forms a heteromeric complex with the TGF$beta; type II receptorCell, 1993
- Inactivation of the Type II Receptor Reveals Two Receptor Pathways for the Diverse TGF-β ActivitiesScience, 1993
- Involvement of p53 mutation in the development of human salivary gland pleomorphic adenomasCancer Letters, 1992
- Control of junB and extracellular matrix protein expression by transforming growth factor-beta 1 is independent of simian virus 40 T antigen-sensitive growth-sensitive growth-inhibitory events.Molecular and Cellular Biology, 1991
- A genetic model for colorectal tumorigenesisCell, 1990
- Biological effects and binding properties of transforming growth factor-β on human oral squamous cell carcinoma cellsExperimental Cell Research, 1990
- A technique for radiolabeling DNA restriction endonuclease fragments to high specific activityAnalytical Biochemistry, 1984
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970